Stockreport

60 Degrees Pharmaceuticals Unveils Name of Chronic Babesiosis Clinical Trial: B-FREE Chronic Babesiosis Study [Yahoo! Finance]

60 Degrees Pharmaceuticals, Inc.  (SXTP) 
PDF A $5K donation from the Company was split between ILADEF and GLA to recognize the winning name B-FREE, a Phase 2 trial, will commence in early November and run for ap [Read more]